technetium-tc-99m-exametazime and idoxifene

technetium-tc-99m-exametazime has been researched along with idoxifene* in 1 studies

Other Studies

1 other study(ies) available for technetium-tc-99m-exametazime and idoxifene

ArticleYear
Pharmacokinetics and biodistribution of radiolabelled idoxifene: prospects for the use of PET in the evaluation of a novel antioestrogen for cancer therapy.
    Nuclear medicine and biology, 1995, Volume: 22, Issue:4

    With a view to evaluating the role of PET imaging in the development of new anticancer drugs, we are investigating the novel antioestrogen pyrrolidino-4-iodotamoxifen (idoxifene). [125I]idoxifene and [131I]idoxifene have been produced in no-carrier-added form using a tributyl stannylated precursor, and the bio-distribution and dynamic behaviour of the compound investigated using syngeneic transplantable mammary tumours in the rat. Our findings support the use of PET imaging with 124I to study the clinical pharmacology of idoxifene. Factors other than hormone receptor levels appear to influence tumour uptake and therefore, possibly the biological effects of this compound.

    Topics: Animals; Estradiol; Estrogen Antagonists; Female; Iodine Radioisotopes; Isotope Labeling; Liver; Mammary Neoplasms, Experimental; Muscle, Skeletal; Organotechnetium Compounds; Ovariectomy; Oximes; Rats; Rats, Inbred Strains; Receptors, Estrogen; Tamoxifen; Technetium Tc 99m Exametazime; Tissue Distribution; Tomography, Emission-Computed; Uterus

1995